| 123 |
Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription |
Dalma Martinovic-Weigelt |
BY-SA |
801: modulation, Unknown
|
2 AOs
|
|
|
| 122 |
Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation |
Dalma Martinovic-Weigelt |
BY-SA |
798: Inhibition, Prolyl hydroxylases
|
2 AOs
|
|
|
| 121 |
Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
793: Increase, Urinary bladder calculi
|
797: Increase, Adenomas/carcinomas (urothelial)
|
|
|
| 120 |
Inhibition of 5α-reductase leading to Leydig cell tumors (in rat) |
Charles Wood |
BY-SA |
1617: Inhibition, 5α-reductase
|
745: Increase, Leydig cell tumors
|
|
|
| 119 |
Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse) |
Charles Wood |
BY-SA |
279: Thyroperoxidase, Inhibition
|
741: Increase, Adenomas/carcinomas (follicular cell)
|
|
|
| 118 |
Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
786: Increase, Cytotoxicity (hepatocytes)
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 117 |
Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
Open for adoption |
25: Agonism, Androgen receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Development |
1.26 |
| 116 |
Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) |
Charles Wood |
BY-SA |
783: Increase, Cytotoxicity (tubular epithelial cells)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
|
|
| 115 |
Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat) |
Charles Wood |
BY-SA |
780: Increase, Cytotoxicity (epithelial cells)
|
779: Increase, Papillomas/carcinomas (squamous cells)
|
|
|
| 114 |
HPPD inhibition leading to corneal papillomas and carcinomas (in rat) |
Charles Wood |
BY-SA |
766: Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme
|
779: Increase, Papillomas/carcinomas (squamous cells)
|
|
|
| 113 |
Glutamate-gated chloride channel activation leading to acute mortality |
Helen Poynton |
BY-SA |
760: Activation, Glutamate-gated chloride channel
|
2 AOs
|
|
|
| 112 |
Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat) |
Charles Wood |
BY-SA |
746: Increase, Dopaminergic activity
|
773: Increase, Endometrial adenocarcinomas
|
|
|
| 111 |
Decrease in androgen receptor activity leading to Leydig cell tumors (in rat) |
Charles Wood |
BY-SA |
1614: Decrease, androgen receptor activation
|
745: Increase, Leydig cell tumors
|
|
|
| 110 |
Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse) |
Charles Wood |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
741: Increase, Adenomas/carcinomas (follicular cell)
|
|
|
| 109 |
Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse) |
Charles Wood |
BY-SA |
770: Increase, Cytotoxicity (club cells)
|
736: Increase, Adenomas/carcinomas (bronchioloalveolar)
|
|
|
| 108 |
Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 107 |
Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat |
Kristin Lichti-Kaiser |
BY-SA |
715: Activation, Constitutive androstane receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Review |
1.17 |
| 106 |
Chemical binding to tubulin in oocytes leading to aneuploid offspring |
Francesco Marchetti |
BY-SA |
718: Binding, Tubulin
|
728: Increase, Aneuploid offspring
|
Under Review |
1.11 |
| 105 |
Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) |
Charles Wood |
BY-SA |
714: Increased, Binding of chemicals to 2u (serum)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
|
|
| 104 |
Altered ion channel activity leading impaired heart function |
Undefined |
BY-SA |
697: impaired, ion channels
|
351: Increased Mortality
|
|
|
| 103 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 102 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 101 |
Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 100 |
Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 99 |
Histamine (H2) receptor antagonism leading to reduced survival |
Kellie Fay |
BY-SA |
638: Antagonism, Histamine Receptor (H2)
|
2 AOs
|
|
|